Drupal.behaviors.print = function(context) {window.print();window.close();}>
Regulus Prices IPO at $10-$12 a Share, Breaks out H1 '12 Financials
September 13, 2012
Regulus Prices IPO at $10-$12 a Share, Breaks out H1 '12 Financials
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Regulus Shares Hover Near IPO Price One Week After Going Public
October 11, 2012 / Gene Silencing News
Regulus Files for Initial Public Offering
August 23, 2012 / Gene Silencing News
People in the News: William Rastetter, Carlo Croce, Tyler Jacks, Phillip Sharp
April 4, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to UNC, Alnylam, FSU, and More
February 7, 2013 / Gene Silencing News
UNC Researchers Report New Details on Role of miR-122 in HCV
December 20, 2012 / Gene Silencing News